The Tryptophan System in Cocaine-Induced Depression.

作者: Francina Fonseca , Joan-Ignasi Mestre-Pintó , Àlex Gómez-Gómez , Diana Martinez-Sanvisens , Rocío Rodríguez-Minguela

DOI: 10.3390/JCM9124103

关键词:

摘要: Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use (CUD). The MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced (CUD-induced-MDD), and their accurate diagnoses treatment a challenge for improving prognoses. This study aimed to assess tryptophan/serotonin (Trp/5-HT) system with acute tryptophan depletion test (ATD), kynurenine pathway subjects CUD-primary-MDD, CUD-induced-MDD, healthy controls. ATD was performed randomized, double-blind, crossover, placebo-controlled design. Markers of enzymatic activity indoleamine 2,3-dioxygenase/tryptophan 2,3-dioxygenase, aminotransferase (KAT) kynureninase were also established. Following ATD, we observed decrease Trp levels all groups. Comparison between CUD-induced-MDD revealed significant differences 5-HT plasma concentrations (512 + 332 ng/mL vs. 107 127 ng/mL, p = 0.039) Kyn/5-HT ratio (11 15 112 136; 0.012), whereas there no CUD-primary-MDD MDD. Effect size coefficients show gradient targeted markers (d range 0.72-1.67). Results suggest different pathogenesis lower participation system, probably more related other neurotransmitter pathways accordingly suggesting need pharmacological approach.

参考文章(56)
Nieves Gómez-Coronado, Rickinder Sethi, Chiara Cristina Bortolasci, Lauren Arancini, Michael Berk, Seetal Dodd, A review of the neurobiological underpinning of comorbid substance use and mood disorders. Journal of Affective Disorders. ,vol. 241, pp. 388- 401 ,(2018) , 10.1016/J.JAD.2018.08.041
Qing Meng, Hyoung-Chun Kim, Seikwan Oh, Yong-Moon Lee, Zhenzhen Hu, Ki-Wan Oh, Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression. Biomolecules & Therapeutics. ,vol. 26, pp. 425- 431 ,(2018) , 10.4062/BIOMOLTHER.2018.141
Marie-Laure Cléry-Melin, Fabrice Jollant, Philip Gorwood, Reward systems and cognitions in Major Depressive Disorder Cns Spectrums. ,vol. 24, pp. 64- 77 ,(2019) , 10.1017/S1092852918001335
Jürgen Rehm, Kevin D. Shield, Global Burden of Disease and the Impact of Mental and Addictive Disorders. Current Psychiatry Reports. ,vol. 21, pp. 10- 10 ,(2019) , 10.1007/S11920-019-0997-0
Jonathan Savitz, The kynurenine pathway: a finger in every pie Molecular Psychiatry. ,vol. 25, pp. 131- 147 ,(2020) , 10.1038/S41380-019-0414-4
Małgorzata Kowalczyk, Janusz Szemraj, Katarzyna Bliźniewska, Michael Maes, Michael Berk, Kuan-Pin Su, Piotr Gałecki, An immune gate of depression - Early neuroimmune development in the formation of the underlying depressive disorder. Pharmacological Reports. ,vol. 71, pp. 1299- 1307 ,(2019) , 10.1016/J.PHAREP.2019.05.022
Michael Roman, Michael R Irwin, None, Novel neuroimmunologic therapeutics in depression: A clinical perspective on what we know so far Brain Behavior and Immunity. ,vol. 83, pp. 7- 21 ,(2020) , 10.1016/J.BBI.2019.09.016
Yanling Zhou, Weijian Liu, Wei Zheng, Chengyu Wang, Yanni Zhan, Xiaofeng Lan, Bin Zhang, Cuiling Zhang, Yuping Ning, Predictors of response to repeated ketamine infusions in depression with suicidal ideation: An ROC curve analysis. Journal of Affective Disorders. ,vol. 264, pp. 263- 271 ,(2020) , 10.1016/J.JAD.2020.01.001
Maria Alías-Ferri, Nuria García-Marchena, Joan Ignasi Mestre-Pintó, Pedro Araos, Esperanza Vergara-Moragues, Francina Fonseca, Francisco González-Saiz, Fernando Rodríguez de Fonseca, Marta Torrens, NEURODEP Group, Trastorno por uso de cocaína y depresión: cuando el diagnóstico clínico no es suficiente Adicciones. pp. 1321- ,(2020) , 10.20882/ADICCIONES.1321
Mahir Fidahic, Antonia Jelicic Kadic, Mislav Radic, Livia Puljak, Celecoxib for rheumatoid arthritis Cochrane Database of Systematic Reviews. ,vol. 2017, pp. 0- 0 ,(2017) , 10.1002/14651858.CD012095.PUB2